Even in the treatment of AD based on medications, options are limited to three cholinesterase inhibitors (ChEIs), namely, donepezil, galantamine, and rivastigmine, and a NMDA receptor antagonist (memantine) [9,10]. The gene discussed is BCHE; the disease is Alzheimer disease.